HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Alert me to new issues of the journal Download to citation manager Reprints/Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Search for Related Content

ERRATUM

Erratum

JONATHAN LEOR, ESTHER GUETTA, MICHA S. FEINBERG, HANAN GALSKI, IRIS BAR, RADKA HOLBOVA, LIRON MILLER, PARVIN ZARIN, DAVID CASTEL, ISRAEL M. BARBASH, ARNON NAGLER

STEM CELLS 2006;24:772–780; doi: 10.1634/stemcells.2005-0212

On page 778, Figure 6 included an incorrect panel B. Here we print the correct figure.

View larger version (12K): [in this window] [in a new window]   Figure 6. Functional effects of CD133+ progenitor cells 1 month after cell or phosphate-buffered saline infusion. By two-dimensional echocardiography, cell therapy improved significantly. (A): Left ventricular (LV) fractional shortening (FS) from baseline (before infusion) versus 1 month after infusion. (B): LV diastolic anterior wall thickness from baseline (before infusion) versus 1 month after infusion. (C): LV systolic anterior wall thickness from baseline (before infusion) versus 1 month after infusion. In contrast, control hearts experienced significant deterioration in those functional parameters. Change (%) in baseline parameter was calculated as [(follow-up parameter-baseline parameter)/baseline parameter] x 100.

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Alert me to new issues of the journal Download to citation manager Reprints/Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Search for Related Content